Pancreatic Cancer Lawyer Reviews Pancreatic Cancer Claims for Cancer Survivors and Families of Those Lost to Cancer by Pancreatic Cancer Lawyer Jason Coomer

As a pancreatic cancer lawyer, Jason Coomer, helps cancer survivors and families of those killed by cancer file claims. Further, he seeks compensation for those injured or families of those killed by dangerours products. More specifically, he reviews Zantac, Belviq, Januvia, Victoza, Byetta, Onglyza, Tradjenta, Bydureon, Janument, Osen, and other defective product cancer cases. For more information on a specific drug or to have a pancreatic cancer claim reviewed please contact Pancreatic Cancer Lawyer Jason Coomer or use our online form for a free case evaluation.

Pancreatic Cancer Lawyer Reviews Defective Diabetes Drug Cancer Cases

As a pancreatic cancer lawyer, Jason Coomer, reviews defective diabetes drug pancreatic cancer claims. He and his co-counsel represent cancer survivors and families of people who have died from pancreatic cancer and took incretin drugs. More specifically, they review pancreatic cancer cases where diabetics took Januvia, Victoza, Byetta, Onglyza, Tradjenta, Bydureon, Janument, Oseni, or other diabetes drugs, then were diagnosed with cancer.

In addition to defective drug and product cancer cases, he also commonly works with pancreatic cancer medical malpractice lawyers on failure to diagnose cases. In reviewing these cases, he needs to know when the pancreatic cancer was diagnosed and when the symptoms were originally reported to a medical provider. He also needs to know the medical providers who missed the diagnosis.

Texas Pancreatic Cancer Lawyer Reviews Pancreatic Cancer Cases From Throughout The United States and World

Texas pancreatic cancer lawyer, Jason Coomer, represents clients from throughout the United States and the world. Further, he commonly works with other pancreatic cancer lawyers on defective product cancer lawsuits. Together, he and his co-counsel help remove and put warning labels on dangerous drugs that increase the risk of pancreatic cancer. They also work to prevent other people from ingesting carcinogenic drugs or being exposed to carcinogenic products. Further, they help families seek compensation from large corporations who knowingly sell dangerous drugs. Anyone who has been diagnosed with pancreatic cancer or families who have lost a loved one from pancreatic cancer, should have their potential claim reviewed. Further, if the pancreatic cancer was caused by a dangerous drug it is important to notify the FDA and file a claim to have prevent future similar cancers or deaths.

Diabetes Drugs in the Incretin Mimetic Class Including Januvia, Janument, Victoza, and Byetta May Cause An Increased Risk of Pancreatic Cancer

Diabetes drugs in the incretin mimetic class may cause an increased health risk of pancreatic cancer and pancreatitis. These incretin diabetes drug include exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto). These drugs work by mimicking the incretin hormones that the body usually produces naturally to stimulate the release of insulin in response to a meal. They are used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. Many of these incretin diabetes drugs already include a black box warning regarding thyroid cancer risk, but evidence is growing that these drugs may also create an increased risk of pancreatic cancer.

Pancreatic Cancer Lawyer Reviews Defective Diabetes Drug Cancer Cases

As a pancreatic cancer lawyer, Jason Coomer, reviews defective diabetes drug pancreatic cancer claims. He and his co-counsel represent cancer survivors and families of people who have died from pancreatic cancer and took incretin drugs. More specifically, they review pancreatic cancer cases where diabetics took Januvia, Victoza, Byetta, Onglyza, Tradjenta, Bydureon, Janument, Oseni, or other diabetes drugs, then were diagnosed with cancer.

In addition to defective drug and product cancer cases, he also commonly works with pancreatic cancer medical malpractice lawyers on failure to diagnose cases. In reviewing these cases, he needs to know when the pancreatic cancer was diagnosed and when the symptoms were originally reported to a medical provider. He also needs to know the medical providers who missed the diagnosis.

Texas Pancreatic Cancer Lawyer Reviews Pancreatic Cancer Cases From Throughout The United States and World

Texas pancreatic cancer lawyer, Jason Coomer, represents clients from throughout the United States and the world. Further, he commonly works with other pancreatic cancer lawyers on defective product cancer lawsuits. Together, he and his co-counsel help remove and put warning labels on dangerous drugs that increase the risk of pancreatic cancer. They also work to prevent other people from ingesting carcinogenic drugs or being exposed to carcinogenic products. Further, they help families seek compensation from large corporations who knowingly sell dangerous drugs. Anyone who has been diagnosed with pancreatic cancer or families who have lost a loved one from pancreatic cancer, should have their potential claim reviewed. Further, if the pancreatic cancer was caused by a dangerous drug it is important to notify the FDA and file a claim to have prevent future similar cancers or deaths.

Diabetes Drugs in the Incretin Mimetic Class Including Januvia, Janument, Victoza, and Byetta May Cause An Increased Risk of Pancreatic Cancer

Diabetes drugs in the incretin mimetic class may cause an increased health risk of pancreatic cancer and pancreatitis. These incretin diabetes drug include exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto). These drugs work by mimicking the incretin hormones that the body usually produces naturally to stimulate the release of insulin in response to a meal. They are used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. Many of these incretin diabetes drugs already include a black box warning regarding thyroid cancer risk, but evidence is growing that these drugs may also create an increased risk of pancreatic cancer.

People Taking Increting Drugs Should Be Aware of Potential Cancer Risks

People who are taking incretin diabetes drugs including: Januvia, Janument, Victoza, Byetta, Onglyza, Tradjenta, Oseni, and other diabetes drugs should be aware of the cancer health risks. If you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer or you have lost a loved one that was taking a diabetes drug and was diagnosed with pancreatic cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible.

• For more information on Januvia and Janumet Pancreatic Cancer, please go to the following web page on Januvia Pancreatic Cancer Lawsuits and Janumet Pancreatic Cancer Lawsuits.
• For more information on Byetta Pancreatic Cancer, please go to the following web page on Byetta Pancreatic Cancer Lawsuits and Exenatide Pancreatic Cancer Lawsuits.
• For more information on Victoza Pancreatic Cancer, please go to the following web page on Victoza Pancreatic Cancer Lawsuits and Victoza Cancer Death Lawsuits.

Pancreatic Cancer Including Pancreatic Adenocarcinoma and other Forms of Exocrine Pancreas Cancers Are Difficult to Diagnose and Are Often Not Diagnosed Until Late in the Course of the Disease

Pancreatic cancer is the fourth leading cause of cancer death for both men and women. It is also one of the most deadly of all types of cancer. This year approximately 45,000 Americans will be diagnosed with pancreatic cancer and about 38,000 will die from it. One of the reasons that pancreatic cancer is so deadly is that it it difficult to diagnose. Further, medical providers often make the the pancreatic cancer diagnosis late in the course of the disease. Early detection of pancreatic cancer is essential to survive and treatment. Further, early detection greatly improves a person's chances of surviving the disease.

As such, those who take specific drugs known to increase cancer risks should be aware of pancreatic cancer symptoms. Further, they should also discuss and seek advice from a qualified medical professional as to the best medications for them. Additionally, they should make sure they and their health care provider watch for any symptoms of pancreatic cancer. More specifically, both should be aware of any weight loss, dark urine and clay-colored stools, back pain, and/or jaundice. Together patients, their families, and their healthcare providers should be aware of the risk factors for pancreatic cancer. They should also watch out for warning signs of pancreatic cancer.

The Pancreas and Pancreatic Cancer

The pancreas is a large organ located behind the stomach and in front of the spine above the level of the belly button. It is about 6 inchens long and looks like a pear on its side. The organ makes and releases enzymes that help with digestion. More specifically, the pancreas performs two main functions: 1) it makes insulin, a hormone that regulates blood sugar levels, and 2) it makes enzymes. These enzymes are released into the intestines to help the body absorb foods, especially fats. The pancreas is made of Exocrine cells and Endocrine cells. Exocrine cells are cells that produce a pancreatic juice that includes enzymes which aid in the digestion of food in the small intestine, breaking up proteins, carbohydrates, and fats.

Endocrine cells are clustered in small groups (called the Islets of Langerhans) scattered throughout the pancreas. These endocrine cells produce important hormones such as insulin, glucagon, and somatostatin. The hormones called insulin and glucagon help your body control blood sugar levels. Tumors can occur in the Exocrine cells or Endocrine cells. The most common type of pancreatic cancer being in the Exocrine cells or the cells that line the ducts that carry digestive enzymes out of the pancreas. Cancerous cells can also occur in the Endocrine cells, but they are called islet cell tumors and are rare.

The Most Common Type of Pancreatic Cancer is Pancreatic Adenocarcinoma Which Includes About 90% of Cases of Pancreatic Cancer: Pancreactic Adenocarcinoma is a Form of Exocrine Pancreas Cancer

The most common kind of pancreatic cancer is pancreatic adenocarcinoma. This type of cancer includes about 90% of the cases of pancreatic cancer. Pancreatic adenocarcinoma is a cancerous overgrowth of exocrine pancreatic cells. It unfortunately is commonly undetected until it is too late for the patient. Pancreatic adenocarcinoma because of late detection often results a fatal diagnosis with very limited survival time. Other forms of exocrine pancreas cancer include: intraductal papillary mucinous neoplasm (IPMN), adenosquamous carcinomas, and acinar cell carcinomas. Additionally, exocrine pancreas cancer includes mucinous cystadenocarcinomas, signet ring cell carcinomas, hepatoid carcinomas, colloid carcinomas, undifferentiated carcinomas, pancreatoblastomas, and undifferentiated carcinomas with osteoclast-like giant cells.

Pancreatic Cancer Detection: Understanding and Identifying Symptoms of Pancreatic Cancer Can Be Important In Early Detection and Treatment of Pancreatic Cancer Resulting in Higher Pancreatic Cancer Survival Rates

Symptoms of pancreatic cancer include: dark urine and clay-colored stools, fatigue and weakness, and jaundice (a yellow color in the skin, mucus membranes, or eyes). Additionally, other symptomes of pancreatic cancer include loss of appetite and weight loss, nausea and vomiting, pain or discomfort in the upper part of the belly or abdomen, back pain, blood clots, diarrhea, and indigestion. If you experience these symptoms, it is important to contact a medical professional for a screening.

Further, the exact cause of pancreatic cancer is not known, but several risk factors

Pancreatic Cancer Screenings and Tests

Medical professionals use several tests to screen for pancreatic cancer. More specifically, they commonly use CT scans, MRIs, and PET scans to obtain images of internal organs including the pancreas. Doctors also can use an ultrasound to make images of your pancreas. To do this, they pass an ultrasound device through an endoscope down the patient's esophagus and into the stomach to obtain images.

Physicians also use biopsies and blood tests to screen for pancreatic cancer. More specifically, they often use endoscope or needle to collect tissue from the pancreas. This tissue can then be biopsied to check for cancer. They can also analyze blood to look for specific proteins or tumor markers that are shed by pancreatic cancer cells. Typically, doctors use a combination of these tests and reported symptoms to diagnose pancreatic cancer.

Pancreatic Cancer Survival Rates

Pancreatic cancer is often not detected early on and is often advanced when it is first found. As such, ninety-five percent of the people diagnosed with this cancer will not be alive 5 years later. Some patients have pancreatic cancer that can be surgically removed are cured. However, in more than 80% of patients the tumor has already spread and cannot be completely removed at the time of diagnosis. In the few cases where pancreatic tumors can be removed by surgery. The standard surgical procedure to remove pancreatic tumors is called a Whipple procedure (pancreatoduodenectomy or pancreaticoduodenectomy). This surgery should be done by an experienced surgeon and at a medical center that performs the procedure often. Some studies suggest that the Whipple procedure is best performed at hospitals that do more than five of these surgeries per year.

Health Care Providers Often Use Radiation and Surgery to Treat Pancreatic Cancer

When the tumor has not spread out of the pancreas, but cannot be removed, radiation therapy and chemotherapy together may be recommended. When the tumor has spread (metastasized) to other organs such as the liver, chemotherapy alone is usually used. The standard chemotherapy drug is gemcitabine, but other drugs may be used. Gemcitabine can help about 25% of patients. Patients whose tumor cannot be totally removed, but who have a blockage of the tubes that transport bile (biliary obstruction) must have that blockage relieved. There are two approaches including surgery and placement of a tiny metal tube (biliary stent) during ERCP.

Managing pain and other symptoms is an important part of treating advanced pancreatic cancer. Palliative care tams and hospice can help with pain and symptom management, and provide psychological support for patients and their families during the illness.

The Diabetes Drug Market is Over $40 Billion Each Year and Growing Rapidly Encouraging Drug Companies To Push Dangerous Diabetes Drugs For Profits

More than 300 million people worldwide suffer from diabetes, including about 30 million Americans. In 2010, the global prevalence of diabetes was estimated to have reached 285 million and predicted to reach 438 million by 2030. The corresponding figures for North America were 37.4 million in 2010 and 53.2 million by 2030 and in Europe 55.2 million in 2010 and 66.2 million in 2030. The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018.

Januvia and Janument Panceatic Cancer Lawyer Jason S. Coomer Reviews Janumet and Januvia Pancreatic Cancer Claims

The diabetes drugs, Januvia and Janumet, may cause an increased risk of pancreatic cancer in patients using Januvia. If you have lost a loved one from Pancreatic Cancer, please report the adverse action to the prescribing medical doctor as soon as possible. As an Januvia Cancer Death Lawyer, Jason S. Coomer, helps families that have lost a family member from cancer including pancreatic cancer. For more information on this topic, please go to the following web page on Januvia Pancreatic Cancer Lawsuits and Janumet Pancreatic Cancer Lawsuits.

The Diabetes Drug Byetta May Cause An Increased Risk of Pancreatic Cancer by Texas Byetta Pancreatic Cancer Lawyer Jason S. Coomer

The injectable diabetes drug, Byetta, may cause an increased risk of pancreatic cancer in patients. If you have lost a loved one from Pancreatic Cancer, please report the adverse action to the prescribing medical doctor as soon as possible. As a Incretin Pancreatic Cancer Lawyer, Jason S. Coomer, helps people that have suffered from defective drugs and families that have lost a family member from cancer including pancreatic cancer. For more information on this topic, please go to the following web page on Byetta Pancreatic Cancer Lawsuits and Exenatide Pancreatic Cancer Lawsuits.

The Diabetes Drug Victoza May Cause An Increased Risk of Pancreatic Cancer by Texas Victoza Pancreatic Cancer Lawyer Jason Coomer

The consumer group, Public Citizen, has filed a petition with the Food and Drug Administration (FDA) requesting that the agency immediately remove the diabetes drug, Victoza, from the market the increasingly prescribed diabetes drug Victoza (liraglutide [rDNA origin] injection) because it puts patients at higher risk of thyroid cancer, pancreatitis, serious allergic reactions and kidney failure that outweigh any documented clinical benefits. Public Citizen claims that the diabetes drug, Victoza, has a number of possible side effects including pancreatic cancer. This side effect is extremely dangerous, because once a person has pancreatic cancer and that cancer spreads, a patient stands just a 1.8% chance of surviving for longer than five years.

If you have lost a loved one from Pancreatic Cancer or have suffered acute pancreatitis, hemorrhagic pancreatitis, accute necrotizing pancreatitis, or pancreas cancer; and have been using Victoza or another diabetes drug, please report the adverse action to the prescribing medical doctor as soon as possible. For more Victoza Pancreatic Cancer Lawsuit, Victoza Cancer Death Lawsuit, or Diabetes Drug Pancreas Cancer Lawsuit information, please feel free to contact Victoza Pancreatic Cancer Lawyer, Victoza Diabetes Drug Cancer Lawyer, and Victoza Pancreas Cancer Death Lawyer Jason Coomer a Texas lawyer, or use our online submission form.

For more information on this topic, please go to the following web page on Victoza Pancreatic Cancer Lawsuits and Victoza Cancer Death Lawsuits.

Pancreatic Cancer Lawyer Jason Coomer Commonly Works With Other Pancreatic Cancer Lawyers From Throughout the United States

Texas Dangerous Drug Attorney Jason Coomer commonly works with other lawyers throughout Texas, the United States, and the World including Houston Pancreatic Cancer Lawyers, San Antonio Pancreatic Cancer Lawyers, Dallas Pancreatic Cancer Lawyers, New York Diabetes Drug Pancreatic Cancer Lawyers, Chicago Diabetes Drug Pancreatic Cancer Lawyers, and other Texas Pancreatic Cancer Death Lawyers. By sharing information and working together, his law firm and other firms throughout World are able to provide better representation for their clients.

If you have lost a loved one from Pancreatic Cancer or have suffered acute pancreatitis, hemorrhagic pancreatitis, accute necrotizing pancreatitis, or pancreas cancer; and have been using a diabetes drug, please report the adverse action to the prescribing medical doctor as soon as possible. For more information on this topic, please feel free to contact Pancreatic Cancer Lawyer, Pancreatic Adenocarcinoma Lawyer, and Pancreas Cancer Lawyer Jason Coomer a Texas lawyer, or use our online submission form.

FDA Information on Sitagliptin (marketed as Januvia and Janumet)

[09-25-2009] FDA is revising the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute pancreatitis in patients using these products.

Sitagliptin, the first in a new class of diabetic drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Eighty-eight post-marketing cases of acute pancreatitis, including two cases of hemorrhagic or necrotizing pancreatitis in patients using sitagliptin, were reported to the Agency between October 16, 2006 and February 9, 2009. Based on these reports, FDA is working with the manufacturer of sitagliptin and sitagliptin/metformin to revise the prescribing information to include:

Information regarding post-marketing reports of acute pancreatitis, including the severe forms, hemorrhagic or necrotizing pancreatitis. Recommending that healthcare professionals monitor patients carefully for the development of pancreatitis after initiation or dose increases of sitagliptin or sitagliptin/metformin, and to discontinue sitagliptin or sitagliptin/metformin if pancreatitis is suspected while using these products. Information noting that sitagliptin has not been studied in patients with a history of pancreatitis. Therefore, it is not known whether these patients are at an increased risk for developing pancreatitis while using sitagliptin or sitagliptin/metformin. Sitagliptin or sitagliptin/metformin should be used with caution and with appropriate monitoring in patients with a history of pancreatitis.

Januvia Pancreatic Cancer Lawsuit Information, Januvia Pancreatitis Lawsuit Information and Januvia Pancreas Cancer Lawsuit Information

Between October 16, 2006 and February 9, 2009, the FDA received 88 post-marketing cases of acute pancreatitis, of which 66 required hospitalization. The FDA review also found that in over half of these cases, the patient?s pancreatitis resolved once Januvia was discontinued. While diabetics are more vulnerable to developing pancreatitis than those without the disease, it does appear that taking Januvia can potentially increase that risk. And, if pancreatitis becomes chronic, the inflammation of the pancreas will alter its normal structure and functions.

Causes and Risk Factors of Pancreatic Cancer

The exact cause of pancreatic cancer is unknown. However, there are several risk factors that increase a person risk of developing pancreatic cancer. These risk factors include obesity, smoking, family history of pancreatic cancer, and some genetic dispositions. Further, exposure to or ingesting carcingenic chemicals increase a person's risk of developing pancreatic cancer. Also, it is more common in people with diabetes and people with long-term inflammation of the pancreas (chronic pancreatitis). It is also thought that the use of incretin drugs, Belviq (weight loss drugs), and ingestion of NDMA can cause pancreatitis resulting in pancreatic cancer.

Scientific Studies Have Shown Several Diabetes Drugs May Cause an Increase Risk of Pancreatic Cancer

Recent scientific studies have shown that several diabetes drugs may cause an increased risk of pancreatic cancer. Persons taking Januvia, Victoza, Byetta, Onglyza, Tradjenta, Bydureon, Janument, Oseni, and other diabetes drugs should be aware of the potential dangers. If you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer or you have lost a loved one that was taking a diabetes drug and was diagnosed with pancreatic cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible.

Pancreatic Cancer Lawyer Commonly Works With Cancer Survivors, Families of People Lost to Cancer, and Other Pancreatic Cancer Lawyers

Pancreatic Cancer Lawyer Jason Coomer commonly works with cancer survivors and those recently diagnosed with pancreatic cancer. He also works with families who have lost a loved one to pancreatic cancer. In working with these people and their families, he commonly works with other pancreatic cancer lawyers to file claims against large corporations who sell dangerous carcinogenic products. Currently, his legal teams are reviewing several cases and are also litigating several pancreatic cancer product cases. For more information, please feel free to contact Dangerous Diabetes Drug Pancreatic Cancer Lawyer Jason Coomer a Texas lawyer, or use our online submission form.